Global Pharmatech, Inc. (GBLP) Stock Analysis
DELISTED
What happened to Global Pharmatech, Inc. (GBLP) stock?
Global Pharmatech, Inc. (GBLP) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
P/E 800.90 means the share price is 800.90 times one year of earnings per share. Market cap $33.3M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Global Pharmatech, Inc. (GBLP). Global Pharmatech, Inc. is a China-based pharmaceutical company focused on the research, production, and development of herbal, bio, chemical, and traditional Chinese medicines, alongside dietary supplements.
Last analyzed: Jun 15, 2026These figures come from statements filed 13 months ago — the most recent this company has published.
Global Pharmatech, Inc. (GBLP) Healthcare & Pipeline Overview
GBLP OTC Market Information
GBLP trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy GBLP shares?
No. GBLP stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for GBLP elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before GBLP stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Global Pharmatech, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.